Literature DB >> 19909372

Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling.

Hisaaki Shinohara1, Tomohiro Kurosaki.   

Abstract

The transcription factor nuclear factor-kappaB (NF-kappaB) contributes to many events in the immune system. Characterization of NF-kappaB has facilitated our understanding of immune cell differentiation, survival, proliferation, and effector functions. Intense research continues to elucidate the role of NF-kappaB, which is shared in several receptor signaling pathways, such as Toll-like receptors, the tumor necrosis factor receptor, and antigen receptors. The specificity of cellular responses emanating from stimulation of these receptors is determined by post-translational modification, or 'fine tuning', which regulates spatiotemporal dynamics of downstream signaling. Understanding the fine tuning mechanisms of NF-kappaB activation is crucial for insights into biological regulation and for understanding how cellular signaling pathways are tightly regulated to guide different cell fates. In this review, we focus on recent advances that illuminate the fine tuning mechanisms of NF-kappaB activation by BCR signaling and have increased our comprehension of complex signal systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909372     DOI: 10.1111/j.1600-065X.2009.00836.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  28 in total

1.  Essential role of TAK1 in regulating mantle cell lymphoma survival.

Authors:  Daniela Buglio; Sangeetha Palakurthi; Kate Byth; Francisco Vega; Dorin Toader; Jamal Saeh; Sattva S Neelapu; Anas Younes
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

Review 2.  Targeting the B cell receptor pathway in chronic lymphocytic leukemia.

Authors:  Matthew S Davids; Jennifer R Brown
Journal:  Leuk Lymphoma       Date:  2012-12

Review 3.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.

Authors:  Michitaka Oho; Risa Nakano; Ryutarou Nakayama; Wataru Sakurai; Azusa Miyamoto; Yoshikazu Masuhiro; Shigemasa Hanazawa
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

Review 5.  Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Authors:  Andrew Aw; Jennifer R Brown
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

6.  Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.

Authors:  Miguel E Moreno-García; Karen Sommer; Hector Rincon-Arano; Michelle Brault; Jun Ninomiya-Tsuji; Lydia E Matesic; David J Rawlings
Journal:  Mol Cell Biol       Date:  2013-01-07       Impact factor: 4.272

7.  Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

Authors:  June H Myklebust; Joshua Brody; Holbrook E Kohrt; Arne Kolstad; Debra K Czerwinski; Sébastien Wälchli; Michael R Green; Gunhild Trøen; Knut Liestøl; Klaus Beiske; Roch Houot; Jan Delabie; Ash A Alizadeh; Jonathan M Irish; Ronald Levy
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113

8.  Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells.

Authors:  Priscilla Doyon; Marc J Servant
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

9.  The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1.

Authors:  Richard J Jones; Dongmin Gu; Chad C Bjorklund; Isere Kuiatse; Alan T Remaley; Tarig Bashir; Veronique Vreys; Robert Z Orlowski
Journal:  J Pharmacol Exp Ther       Date:  2013-07-02       Impact factor: 4.030

10.  Protein kinase Cβ is required for lupus development in Sle mice.

Authors:  David Oleksyn; Mary Pulvino; Jiyong Zhao; Ravi Misra; Aram Vosoughi; Scott Jenks; Christopher Tipton; Frances Lund; George Schwartz; Bruce Goldman; Chandra Mohan; Kamal Mehta; Madhu Mehta; Michael Leitgets; Ignacio Sanz; Luojing Chen
Journal:  Arthritis Rheum       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.